首页 > 最新文献

Chinese Journal of Asthma最新文献

英文 中文
Efficacy and safety of intravenous antibiotics combined with inhalation of amikacin versus intravenous antibiotics for treatment of ventilator-associated pneumonia: a systematic review and meta-analysis 静脉注射抗生素联合吸入阿米卡星与静脉注射抗生素治疗呼吸机相关性肺炎的疗效和安全性:一项系统回顾和荟萃分析
Pub Date : 2020-04-05 DOI: 10.3760/CMA.J.CN131368-20190429-00659
Chuxin Huang, Xiaona Zhan, J. Su, Changxi Miao, Jiamin Yao, Yuechun Lin, Luqian Zhou
Objective Reviewing and integrating published literature at home and abroad by meta-analysis to compare the efficacy and safety of aerosolized amikacin for treatment of ventilator-associated pneumonia (VAP). Methods Comprehensive searches were performed from the PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, VIP, China national knowledge internet and Wanfang database to acquire randomized controlled trials (RCTs) comparing intravenous antibiotics combined with inhalation of amikacin treatment with intravenous antibiotics and the data were collected from the time of establishment of databases to November 2018.The methodological quality of the included studies were assessed following the preferred reporting items for systematic reviews and meta-analysis guidelines.Statistical analysis on the data was performed by RevMan 5.3 software. Results Totally eight RCTs were included in the meta-analysis.Pooled analysis showed that compared to the intravenous antibiotics, intravenous antibiotics combined with inhalation of amikacin treatment significantly improved the clinical cure rate (OR=2.59, 95% CI: 1.87-3.59, P<0.000 01), bacterial clearance rate (OR=2.87, 95% CI: 1.93-4.27, P<0.000 01), and weaning rate (OR=1.88, 95%CI: 1.16-3.04, P=0.01). The death rate (OR=1.39, 95%CI: 0.86-2.24, P=0.18), the happening of bronchospasm (OR=2.30, 95%CI: 1.00-5.30, P=0.05) and renal dysfunction rate (OR=0.61, 95%CI: 0.34-1.11, P=0.10) were not significantly different for intravenous antibiotics combined with inhalation of amikacin versus intravenous antibiotics. Conclusions Patients with VAP received higher rate of clinical cure rate, bacterial clearance rate, and weaning rate and by using intravenous antibiotics combined with inhalation of amikacin treatment, whereas could not reduce the rate of mortality and didn′t increase the happening of bronchospasm and renal dysfunction rate. Key words: Pneumonia, ventilator-associated; Meta-analysis; Inhalation; Amikacin; Intravenous antibiotics
目的通过荟萃分析对国内外已发表文献进行梳理和整合,比较雾化阿米卡星治疗呼吸机相关性肺炎(VAP)的疗效和安全性。方法综合检索PubMed、Embase、Cochrane中央对照试验注册库、Web of Science、VIP、中国国家知识网、万方数据库,获取静脉抗生素联合吸入阿米卡星治疗与静脉抗生素比较的随机对照试验(RCTs),数据采集自建库时至2018年11月。纳入研究的方法学质量按照系统评价和荟萃分析指南的首选报告项目进行评估。采用RevMan 5.3软件对数据进行统计分析。结果meta分析共纳入8项rct。合并分析显示,与静脉注射抗生素相比,静脉注射抗生素联合吸入阿米卡星治疗显著提高了患儿的临床治愈率(OR=2.59, 95%CI: 1.87 ~ 3.59, P< 0.0001)、细菌清除率(OR=2.87, 95%CI: 1.93 ~ 4.27, P< 0.0001)和脱机率(OR=1.88, 95%CI: 1.16 ~ 3.04, P=0.01)。静脉注射抗生素联合吸入阿米卡星与静脉注射抗生素的死亡率(OR=1.39, 95%CI: 0.86 ~ 2.24, P=0.18)、支气管痉挛发生率(OR=2.30, 95%CI: 1.00 ~ 5.30, P=0.05)、肾功能不全发生率(OR=0.61, 95%CI: 0.34 ~ 1.11, P=0.10)差异无统计学意义。结论VAP患者临床治愈率、细菌清除率、脱机率较高,静脉应用抗生素联合吸入阿米卡星治疗,但不能降低病死率,且未增加支气管痉挛的发生和肾功能不全率。关键词:肺炎;呼吸机相关性;荟萃分析;吸入;阿米卡星;静脉注射抗生素
{"title":"Efficacy and safety of intravenous antibiotics combined with inhalation of amikacin versus intravenous antibiotics for treatment of ventilator-associated pneumonia: a systematic review and meta-analysis","authors":"Chuxin Huang, Xiaona Zhan, J. Su, Changxi Miao, Jiamin Yao, Yuechun Lin, Luqian Zhou","doi":"10.3760/CMA.J.CN131368-20190429-00659","DOIUrl":"https://doi.org/10.3760/CMA.J.CN131368-20190429-00659","url":null,"abstract":"Objective \u0000Reviewing and integrating published literature at home and abroad by meta-analysis to compare the efficacy and safety of aerosolized amikacin for treatment of ventilator-associated pneumonia (VAP). \u0000 \u0000 \u0000Methods \u0000Comprehensive searches were performed from the PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, VIP, China national knowledge internet and Wanfang database to acquire randomized controlled trials (RCTs) comparing intravenous antibiotics combined with inhalation of amikacin treatment with intravenous antibiotics and the data were collected from the time of establishment of databases to November 2018.The methodological quality of the included studies were assessed following the preferred reporting items for systematic reviews and meta-analysis guidelines.Statistical analysis on the data was performed by RevMan 5.3 software. \u0000 \u0000 \u0000Results \u0000Totally eight RCTs were included in the meta-analysis.Pooled analysis showed that compared to the intravenous antibiotics, intravenous antibiotics combined with inhalation of amikacin treatment significantly improved the clinical cure rate (OR=2.59, 95% CI: 1.87-3.59, P<0.000 01), bacterial clearance rate (OR=2.87, 95% CI: 1.93-4.27, P<0.000 01), and weaning rate (OR=1.88, 95%CI: 1.16-3.04, P=0.01). The death rate (OR=1.39, 95%CI: 0.86-2.24, P=0.18), the happening of bronchospasm (OR=2.30, 95%CI: 1.00-5.30, P=0.05) and renal dysfunction rate (OR=0.61, 95%CI: 0.34-1.11, P=0.10) were not significantly different for intravenous antibiotics combined with inhalation of amikacin versus intravenous antibiotics. \u0000 \u0000 \u0000Conclusions \u0000Patients with VAP received higher rate of clinical cure rate, bacterial clearance rate, and weaning rate and by using intravenous antibiotics combined with inhalation of amikacin treatment, whereas could not reduce the rate of mortality and didn′t increase the happening of bronchospasm and renal dysfunction rate. \u0000 \u0000 \u0000Key words: \u0000Pneumonia, ventilator-associated; Meta-analysis; Inhalation; Amikacin; Intravenous antibiotics","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"27 1","pages":"521-530"},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84548095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of silencing of GRHL2 on proliferation and apoptosis of lung cancer A549 cells GRHL2沉默对肺癌A549细胞增殖和凋亡的影响
Pub Date : 2020-04-05 DOI: 10.3760/CMA.J.CN131368-20190524-00774
Mingli Wei, N. Huang
Objective To investigate the effect of GRHL2 silencing on proliferation and apoptosis of lung cancer A549 cells. Methods Using RNA interference technology, the expression vector of GRHL2 silenced lentivirus was constructed to infect lung cancer A549 cells, the experiment was divided into the experimental group (GRHL2 silences the A549 cell line infected by lentivirus), the negative control group (the A549 cell line infected by no-load lentivirus), the blank control group (the A549 cell line without any treatment). The intensity of green fluorescent protein was observed by inverted fluorescence microscope, and the expression levels of GRHL2 mRNA and protein in lung cancer A549 cells were detected by quantitative real-time polymerase chain reaction and Western blot.Cell counting kit-8 was used to detect the effect of GRHL2 silencing on A549 cell proliferation.Annexin V-APC /PI reagents and flow analysis were used to analyze the effect of GRHL2 silencing on the apoptosis of A549 cells. Results The expression levels of GRHL2 mRNA and protein in the experimental group were significantly decreased than the negative control groupand blank control group (F=48.13, 42.57, both P<0.05), the proliferation ability of A549 cells was significantly decreased (F=65.64, P<0.05), and apoptosis was significantly increased (F=56.76, P<0.05). Conclusions Targeted silencing of GRHL2 can significantly inhibit the proliferation and promote apoptosis of lung cancer A549 cells, and GRHL2 is expected to become a new target for clinical lung cancer targeted therapy. Key words: Lentivirus infections; Cell proliferation; Apoptosis; GRHL2; A549
目的探讨GRHL2沉默对肺癌A549细胞增殖和凋亡的影响。方法采用RNA干扰技术构建GRHL2沉默慢病毒表达载体,感染肺癌A549细胞,实验分为实验组(GRHL2沉默慢病毒感染的A549细胞系)、阴性对照组(空载慢病毒感染的A549细胞系)、空白对照组(未经任何处理的A549细胞系)。倒置荧光显微镜下观察绿色荧光蛋白强度,实时荧光定量聚合酶链反应和Western blot检测肺癌A549细胞中GRHL2 mRNA和蛋白的表达水平。细胞计数试剂盒-8检测GRHL2沉默对A549细胞增殖的影响。采用Annexin V-APC /PI试剂和流量分析分析GRHL2沉默对A549细胞凋亡的影响。结果实验组GRHL2 mRNA和蛋白表达量均显著低于阴性对照组和空白对照组(F=48.13、42.57,P均<0.05),A549细胞增殖能力显著降低(F=65.64, P<0.05),细胞凋亡显著增加(F=56.76, P<0.05)。结论靶向沉默GRHL2可显著抑制肺癌A549细胞的增殖,促进细胞凋亡,GRHL2有望成为临床肺癌靶向治疗的新靶点。关键词:慢病毒感染;细胞增殖;细胞凋亡;GRHL2;A549
{"title":"Effect of silencing of GRHL2 on proliferation and apoptosis of lung cancer A549 cells","authors":"Mingli Wei, N. Huang","doi":"10.3760/CMA.J.CN131368-20190524-00774","DOIUrl":"https://doi.org/10.3760/CMA.J.CN131368-20190524-00774","url":null,"abstract":"Objective \u0000To investigate the effect of GRHL2 silencing on proliferation and apoptosis of lung cancer A549 cells. \u0000 \u0000 \u0000Methods \u0000Using RNA interference technology, the expression vector of GRHL2 silenced lentivirus was constructed to infect lung cancer A549 cells, the experiment was divided into the experimental group (GRHL2 silences the A549 cell line infected by lentivirus), the negative control group (the A549 cell line infected by no-load lentivirus), the blank control group (the A549 cell line without any treatment). The intensity of green fluorescent protein was observed by inverted fluorescence microscope, and the expression levels of GRHL2 mRNA and protein in lung cancer A549 cells were detected by quantitative real-time polymerase chain reaction and Western blot.Cell counting kit-8 was used to detect the effect of GRHL2 silencing on A549 cell proliferation.Annexin V-APC /PI reagents and flow analysis were used to analyze the effect of GRHL2 silencing on the apoptosis of A549 cells. \u0000 \u0000 \u0000Results \u0000The expression levels of GRHL2 mRNA and protein in the experimental group were significantly decreased than the negative control groupand blank control group (F=48.13, 42.57, both P<0.05), the proliferation ability of A549 cells was significantly decreased (F=65.64, P<0.05), and apoptosis was significantly increased (F=56.76, P<0.05). \u0000 \u0000 \u0000Conclusions \u0000Targeted silencing of GRHL2 can significantly inhibit the proliferation and promote apoptosis of lung cancer A549 cells, and GRHL2 is expected to become a new target for clinical lung cancer targeted therapy. \u0000 \u0000 \u0000Key words: \u0000Lentivirus infections; Cell proliferation; Apoptosis; GRHL2; A549","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"32 2 1","pages":"481-486"},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87352556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polymorphisms in the survivin gene and the risk of lung cancer survivin基因的多态性与肺癌的风险
Pub Date : 2020-04-05 DOI: 10.3760/CMA.J.CN131368-20190528-00782
Wei-wei Shi, Fuhui Chen
Objective To explore the relationship between 9194A/G polymorphism of survivin gene and lung cancer, and whether it is related to smoking factors. Methods From March 2011 to April 2012, 133 lung cancer patients from the Second Affiliated Hospital of Harbin Medical University were selected as the lung cancer group and 150 healthy people as the control group.By the case-control study method, polymerase chain reaction-restriction fragment length polymorphism method was used for analyzing the 9194A/G polymorphism of survivin gene in peripheral blood samples.Further stratified analysis according to smoking degree. Results The genotype frequencies of 9194A/G of survivin gene for 9194AA, 9194AG, and 9194GG were 61.33%, 33.33%, and 5.33% in the control group, and 64.66%, 30.83%, and 4.51% in the lung cancer group.There was no statistical difference between the two groups (χ2=0.358, P=0.836). There was no significant difference in the composition of survivin gene 9194A/G between lung cancer group and control group under different smoking conditions (all P>0.05). Conclusions There may be no association between the 9194A/G polymorphism of survivin gene and the lung cancer.There was no significant association between the 9194A/G polymorphism of survivin gene and smoking. Key words: Lung neoplasms; Smoking; Gene polymorphism; survivin
目的探讨survivin基因9194A/G多态性与肺癌的关系,以及是否与吸烟因素有关。方法选取2011年3月~ 2012年4月哈尔滨医科大学附属第二医院肺癌患者133例作为肺癌组,150例健康人群作为对照组。采用病例对照研究方法,采用聚合酶链反应-限制性片段长度多态性方法对外周血样本中survivin基因9194A/G多态性进行分析。根据吸烟程度进一步分层分析。结果9194AA、9194AG、9194GG的survivin基因9194A/G基因型频率在对照组分别为61.33%、33.33%、5.33%,在肺癌组分别为64.66%、30.83%、4.51%。两组间比较差异无统计学意义(χ2=0.358, P=0.836)。肺癌组与对照组在不同吸烟条件下survivin基因9194A/G组成差异无统计学意义(均P>0.05)。结论survivin基因9194A/G多态性与肺癌的发生可能无相关性。survivin基因9194A/G多态性与吸烟无显著相关性。关键词:肺肿瘤;吸烟;基因多态性;生存素
{"title":"Polymorphisms in the survivin gene and the risk of lung cancer","authors":"Wei-wei Shi, Fuhui Chen","doi":"10.3760/CMA.J.CN131368-20190528-00782","DOIUrl":"https://doi.org/10.3760/CMA.J.CN131368-20190528-00782","url":null,"abstract":"Objective \u0000To explore the relationship between 9194A/G polymorphism of survivin gene and lung cancer, and whether it is related to smoking factors. \u0000 \u0000 \u0000Methods \u0000From March 2011 to April 2012, 133 lung cancer patients from the Second Affiliated Hospital of Harbin Medical University were selected as the lung cancer group and 150 healthy people as the control group.By the case-control study method, polymerase chain reaction-restriction fragment length polymorphism method was used for analyzing the 9194A/G polymorphism of survivin gene in peripheral blood samples.Further stratified analysis according to smoking degree. \u0000 \u0000 \u0000Results \u0000The genotype frequencies of 9194A/G of survivin gene for 9194AA, 9194AG, and 9194GG were 61.33%, 33.33%, and 5.33% in the control group, and 64.66%, 30.83%, and 4.51% in the lung cancer group.There was no statistical difference between the two groups (χ2=0.358, P=0.836). There was no significant difference in the composition of survivin gene 9194A/G between lung cancer group and control group under different smoking conditions (all P>0.05). \u0000 \u0000 \u0000Conclusions \u0000There may be no association between the 9194A/G polymorphism of survivin gene and the lung cancer.There was no significant association between the 9194A/G polymorphism of survivin gene and smoking. \u0000 \u0000 \u0000Key words: \u0000Lung neoplasms; Smoking; Gene polymorphism; survivin","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"45 1","pages":"512-515"},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88305167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The expression and significance of long-chain non-coding RNA linc00261 in non-small cell lung cancer 长链非编码RNA linc00261在非小细胞肺癌中的表达及意义
Pub Date : 2020-04-05 DOI: 10.3760/CMA.J.CN131368-20190226-00253
Lei Wang, Xinxiao Wang, Zhong Chen, Bin Shen, Zongxing Ou
Objective To investigate the expression of long-chain non-coding RNA (lncRNA) linc00261 in non-small cell lung cancer (NSCLC) and its clinical significance. Methods Included in 100 patients with NSCLC were admitted to Haikou Hospital Affiliated to Xiangya School of Medicine, Central South University from February 2017 to September 2018 were enrolled in this study.Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect the expression of lncRNA linc00261 in cancer tissues and adjacent tissues of patients, and to analyze the relationship between the expression of lncRNA linc00261 and clinicopathological characteristics of patients.The expression plasmid of lncRNA linc00261 was designed and synthesized and transfected into A549 cells.The expression of lncRNA linc00261 in transfected cells was detected by qRT-PCR, the proliferation of transfected cells was detected by MTT, and the apoptosis of transfected cells was detected by flow cytometry. Results The results of qRT-PCR showed that the average relative expression of lncRNA linc0026 1 in cancer tissues of 100 NSCLC patients was significantly lower than that in adjacent tissues (1.19±0.23), with statistical significance (t=7.753, P 0.05), but the relative expression of lncRNA linc00261 in cancer tissues of NSCLC patients with different tissue differentiation degree, clinical stage and lymph node metastasis had statistical significance (all P 0.05). After 48 hours, 72 hours and 96 hours of transfection, the cell proliferation of A549 cells transfected with the expression plasmid of lncRNA linc00261 was significantly lower than that of the negative control group and the blank control group (t=3.187, 5.549, both P<0.05). The results of flow cytometry showed that the apoptotic rate of A549 cells transfected with the expression plasmid of lncRNA linc00261 was significantly higher than that of the negative control group and the blank control group after 48 hours of transfection (χ2=4.175, 6.093, both P<0.05). Conclusions lncRNA linc00261 is down-regulated in cancer tissues of NSCLC patients and is related to the development of NSCLC.It may play an anti-oncogene role in NSCLC.Overexpression of lncRNA linc0026 can inhibit the proliferation and induce apoptosis of NSCLC cells, which may become a potential therapeutic target of NSCLC. Key words: Carcinoma, non-small-cell lung; Cell proliferation; Apoptosis; Long-chain non-coding RNA; linc00261
目的探讨长链非编码RNA (lncRNA) linc00261在非小细胞肺癌(NSCLC)中的表达及其临床意义。方法选取2017年2月至2018年9月中南大学湘雅医学院附属海口医院收治的100例非小细胞肺癌患者为研究对象。采用实时定量逆转录聚合酶链反应(qRT-PCR)检测lncRNA linc00261在患者癌组织及癌旁组织中的表达,分析lncRNA linc00261的表达与患者临床病理特征的关系。设计合成lncRNA linc00261表达质粒,转染A549细胞。采用qRT-PCR检测转染细胞中lncRNA linc00261的表达,MTT检测转染细胞的增殖,流式细胞术检测转染细胞的凋亡情况。结果qRT-PCR结果显示,lncRNA linc00261在100例NSCLC患者癌组织中的平均相对表达量显著低于癌旁组织(1.19±0.23),差异有统计学意义(t=7.753, P 0.05),而lncRNA linc00261在不同组织分化程度、临床分期及淋巴结转移的NSCLC患者癌组织中的相对表达量差异有统计学意义(均P 0.05)。转染48小时、72小时、96小时后,转染lncRNA表达质粒linc00261的A549细胞增殖能力显著低于阴性对照组和空白对照组(t=3.187、5.549,P均<0.05)。流式细胞术结果显示,转染lncRNA表达质粒linc00261后48 h, A549细胞的凋亡率显著高于阴性对照组和空白对照组(χ2=4.175、6.093,P均<0.05)。结论lncRNA linc00261在非小细胞肺癌患者癌组织中表达下调,与非小细胞肺癌的发生发展有关。它可能在非小细胞肺癌中发挥抑癌基因作用。lncRNA linc0026过表达可抑制非小细胞肺癌细胞增殖并诱导细胞凋亡,可能成为治疗非小细胞肺癌的潜在靶点。关键词:肺癌,非小细胞肺;细胞增殖;细胞凋亡;长链非编码RNA;linc00261
{"title":"The expression and significance of long-chain non-coding RNA linc00261 in non-small cell lung cancer","authors":"Lei Wang, Xinxiao Wang, Zhong Chen, Bin Shen, Zongxing Ou","doi":"10.3760/CMA.J.CN131368-20190226-00253","DOIUrl":"https://doi.org/10.3760/CMA.J.CN131368-20190226-00253","url":null,"abstract":"Objective \u0000To investigate the expression of long-chain non-coding RNA (lncRNA) linc00261 in non-small cell lung cancer (NSCLC) and its clinical significance. \u0000 \u0000 \u0000Methods \u0000Included in 100 patients with NSCLC were admitted to Haikou Hospital Affiliated to Xiangya School of Medicine, Central South University from February 2017 to September 2018 were enrolled in this study.Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect the expression of lncRNA linc00261 in cancer tissues and adjacent tissues of patients, and to analyze the relationship between the expression of lncRNA linc00261 and clinicopathological characteristics of patients.The expression plasmid of lncRNA linc00261 was designed and synthesized and transfected into A549 cells.The expression of lncRNA linc00261 in transfected cells was detected by qRT-PCR, the proliferation of transfected cells was detected by MTT, and the apoptosis of transfected cells was detected by flow cytometry. \u0000 \u0000 \u0000Results \u0000The results of qRT-PCR showed that the average relative expression of lncRNA linc0026 1 in cancer tissues of 100 NSCLC patients was significantly lower than that in adjacent tissues (1.19±0.23), with statistical significance (t=7.753, P 0.05), but the relative expression of lncRNA linc00261 in cancer tissues of NSCLC patients with different tissue differentiation degree, clinical stage and lymph node metastasis had statistical significance (all P 0.05). After 48 hours, 72 hours and 96 hours of transfection, the cell proliferation of A549 cells transfected with the expression plasmid of lncRNA linc00261 was significantly lower than that of the negative control group and the blank control group (t=3.187, 5.549, both P<0.05). The results of flow cytometry showed that the apoptotic rate of A549 cells transfected with the expression plasmid of lncRNA linc00261 was significantly higher than that of the negative control group and the blank control group after 48 hours of transfection (χ2=4.175, 6.093, both P<0.05). \u0000 \u0000 \u0000Conclusions \u0000lncRNA linc00261 is down-regulated in cancer tissues of NSCLC patients and is related to the development of NSCLC.It may play an anti-oncogene role in NSCLC.Overexpression of lncRNA linc0026 can inhibit the proliferation and induce apoptosis of NSCLC cells, which may become a potential therapeutic target of NSCLC. \u0000 \u0000 \u0000Key words: \u0000Carcinoma, non-small-cell lung; Cell proliferation; Apoptosis; Long-chain non-coding RNA; linc00261","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"184 1","pages":"506-511"},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91528111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between obstructive sleep apnea and optic neuropathy 阻塞性睡眠呼吸暂停与视神经病变的关系
Pub Date : 2020-04-05 DOI: 10.3760/CMA.J.CN131368-20190530-00795
Yuanyuan Fang, Hui-guo Liu
Obstructive sleep apnea hypopnea syndrome (OSAHS) is a common respiratory disease.In recent years, a growing number of studies reported on the OSAHS associated with optic nerve disease, including primary open-angle glaucoma, non-arterial anterior ischemic optic neuropathy, papilledema, etc.This paper reviews the relationship between OSAHS and optic neuropathy and the pathogenesis, as well as the treatment.The purpose is to prompt OSAHS patients to pay more attention to eye symptoms, and to provide new ideas for respiratory and ophthalmic diagnosis and treatment. Key words: Sleep apnea, obstructive; Optic nerve diseases; Continuous positive airway pressure
阻塞性睡眠呼吸暂停低通气综合征(OSAHS)是一种常见的呼吸道疾病。近年来,越来越多的研究报道了OSAHS与视神经疾病的关系,包括原发性开角型青光眼、非动脉性前缺血性视神经病变、视神经乳头水肿等。本文就OSAHS与视神经病变的关系、发病机制及治疗进行综述。旨在提示OSAHS患者重视眼部症状,为呼吸道及眼科诊疗提供新思路。关键词:睡眠呼吸暂停;阻塞性;视神经疾病;持续气道正压
{"title":"The relationship between obstructive sleep apnea and optic neuropathy","authors":"Yuanyuan Fang, Hui-guo Liu","doi":"10.3760/CMA.J.CN131368-20190530-00795","DOIUrl":"https://doi.org/10.3760/CMA.J.CN131368-20190530-00795","url":null,"abstract":"Obstructive sleep apnea hypopnea syndrome (OSAHS) is a common respiratory disease.In recent years, a growing number of studies reported on the OSAHS associated with optic nerve disease, including primary open-angle glaucoma, non-arterial anterior ischemic optic neuropathy, papilledema, etc.This paper reviews the relationship between OSAHS and optic neuropathy and the pathogenesis, as well as the treatment.The purpose is to prompt OSAHS patients to pay more attention to eye symptoms, and to provide new ideas for respiratory and ophthalmic diagnosis and treatment. \u0000 \u0000Key words: \u0000Sleep apnea, obstructive; Optic nerve diseases; Continuous positive airway pressure","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"18 1","pages":"551-555"},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76839195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cox-2 inhibitors in combination with cisplatin for lung cancer research progress of angiogenesis Cox-2抑制剂联合顺铂治疗肺癌血管生成的研究进展
Pub Date : 2020-04-05 DOI: 10.3760/CMA.J.CN131368-20190725-01055
Huiyan Wei, Qing Zhang
Objective To investigate the selective cyclooxygenase-2 (COX-2) inhibitor nimesulide (NIM) and in combination with cisplatin (DDP) on A549 cells in nude mice transplanted tumor angiogenesis and its mechanism for the treatment oflung cancer in vivo. Methods Lung cancer A549 cells and established A549 lung xenografts in nude mice model.According to the method of random number table, the subjects were divided into four groups for drug intervention: control group, NIM group, DDP group, NIM+ DDP group, each group of 8, and the general state was observed.Mice were killed by cervical dislocation on 22nd days, then obtained tumor tissues, weighed tumor, measured tumor diameter and calculated tumor inhibition rate.To clarify the influence of nimesulide alone or in combination with cisplatin in A549 lung cancer xenograft tumor neovascularization, labeled microvessel with CD31 and counted microvessel density using microvessel counts.Immunohistochemistry was used to detect the expression of endovascular endothelial growth factor in lung cancer A549 in nude mice. Results In this study, a nude mouse model of lung cancer A549 was successfully constructed.The tumor volume of NIM+ DDP group increased more slowly than the other three groups on the 9th, 13th, 17th and 21st day (all P<0.001). Nim+ DDP group had the largest tumor inhibition rate.The microvessel density of NIM+ DDP group was lower than that of the other three groups (F=27.861, P<0.001). Conclusions The selective COX-2 inhibitors could inhibit angiogenesis, suggesting that selective COX-2 inhibitors have anti-tumor capabilities and may be used as a lung cancer targeted therapy.The selective COX-2 inhibitor combined with cisplatin had a more significant inhibitory effect on the expression of neovascularization factors and the growth of transplanted tumor in nude mice with lung cancer A549 cells. Key words: Lung neoplasms; Vascular endothelial growth factors; Inhibition of cyclooxygenase-2
目的探讨选择性环氧化酶-2 (COX-2)抑制剂尼美舒利(NIM)及联合顺铂(DDP)对裸鼠移植瘤A549细胞血管生成的影响及其体内治疗恶性肿瘤的机制。方法建立肺癌A549细胞和A549裸鼠肺异种移植模型。按照随机数字表法将受试者分为4组进行药物干预:对照组、NIM组、DDP组、NIM+ DDP组,每组8人,观察一般情况。第22天颈椎脱位处死小鼠,取肿瘤组织,称重,测量肿瘤直径,计算肿瘤抑制率。为了明确尼美舒利单用或联合顺铂对A549肺癌异种移植肿瘤新生血管的影响,用CD31标记微血管,用微血管计数计算微血管密度。采用免疫组化方法检测肺癌A549裸鼠血管内皮生长因子的表达。结果本研究成功构建了肺癌A549裸鼠模型。NIM+ DDP组肿瘤体积在第9天、第13天、第17天、第21天的增大速度较其他3组慢(P<0.001)。Nim+ DDP组肿瘤抑制率最大。NIM+ DDP组微血管密度低于其他3组(F=27.861, P<0.001)。结论选择性COX-2抑制剂可抑制血管生成,提示选择性COX-2抑制剂具有抗肿瘤能力,可作为肺癌的靶向治疗药物。选择性COX-2抑制剂联合顺铂对肺癌A549细胞裸鼠新生血管因子表达及移植瘤生长的抑制作用更为显著。关键词:肺肿瘤;血管内皮生长因子;环氧化酶-2的抑制作用
{"title":"Cox-2 inhibitors in combination with cisplatin for lung cancer research progress of angiogenesis","authors":"Huiyan Wei, Qing Zhang","doi":"10.3760/CMA.J.CN131368-20190725-01055","DOIUrl":"https://doi.org/10.3760/CMA.J.CN131368-20190725-01055","url":null,"abstract":"Objective \u0000To investigate the selective cyclooxygenase-2 (COX-2) inhibitor nimesulide (NIM) and in combination with cisplatin (DDP) on A549 cells in nude mice transplanted tumor angiogenesis and its mechanism for the treatment oflung cancer in vivo. \u0000 \u0000 \u0000Methods \u0000Lung cancer A549 cells and established A549 lung xenografts in nude mice model.According to the method of random number table, the subjects were divided into four groups for drug intervention: control group, NIM group, DDP group, NIM+ DDP group, each group of 8, and the general state was observed.Mice were killed by cervical dislocation on 22nd days, then obtained tumor tissues, weighed tumor, measured tumor diameter and calculated tumor inhibition rate.To clarify the influence of nimesulide alone or in combination with cisplatin in A549 lung cancer xenograft tumor neovascularization, labeled microvessel with CD31 and counted microvessel density using microvessel counts.Immunohistochemistry was used to detect the expression of endovascular endothelial growth factor in lung cancer A549 in nude mice. \u0000 \u0000 \u0000Results \u0000In this study, a nude mouse model of lung cancer A549 was successfully constructed.The tumor volume of NIM+ DDP group increased more slowly than the other three groups on the 9th, 13th, 17th and 21st day (all P<0.001). Nim+ DDP group had the largest tumor inhibition rate.The microvessel density of NIM+ DDP group was lower than that of the other three groups (F=27.861, P<0.001). \u0000 \u0000 \u0000Conclusions \u0000The selective COX-2 inhibitors could inhibit angiogenesis, suggesting that selective COX-2 inhibitors have anti-tumor capabilities and may be used as a lung cancer targeted therapy.The selective COX-2 inhibitor combined with cisplatin had a more significant inhibitory effect on the expression of neovascularization factors and the growth of transplanted tumor in nude mice with lung cancer A549 cells. \u0000 \u0000 \u0000Key words: \u0000Lung neoplasms; Vascular endothelial growth factors; Inhibition of cyclooxygenase-2","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"1940 1","pages":"487-492"},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91216944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The tumor promoting mechanism of circulating and tumor tissue neutrophils 循环及肿瘤组织中性粒细胞的促肿瘤机制
Pub Date : 2020-04-05 DOI: 10.3760/CMA.J.CN131368-20191015-01416
Ji-Zhong Yin, Bing Li
Neutrophils are the most common inflammation cells in the human body and the most abundant cells in the tumor microenvironment.Normal neutrophils are derived from bone marrow hematopoietic stem cells, which have the function of clearing pathogens and tissue repair.However, In the tumor background, the subpopulations of neutrophils can transform to Myeloid-derived suppressor cells (MDSCs), which is a kind of immature neutrophils with strong immunosuppressive effects.Circulating MDSCs inhibit the anti-tumor immunity of T lymphocytes by producing reactive oxygen species and arginase, and release neutrophil extracellular traps to promote tumor cell transport in blood.MDSCs in tumor tissues inhibit T lymphocytes function by expressing PD-L1, and can also release vascular endothelial growth factor to promote angiogenesis, release metal matrix protease to induce epithelial-mesenchymal transition, thereby aggravating tumor progression.Neutrophils play an important role in the development of tumorigenesis.This article reviews the origin of neutrophils and the mechanism by which neutrophils promote tumor progression in circulation and tumor tissues. Key words: Tumor microenvironment; Biological markers; Neutrophils; Myeloid-derived suppressor cells; Immunity inhibition
中性粒细胞是人体内最常见的炎症细胞,也是肿瘤微环境中最丰富的细胞。正常中性粒细胞来源于骨髓造血干细胞,具有清除病原体和组织修复的功能。然而,在肿瘤背景下,中性粒细胞亚群可以转化为髓源性抑制细胞(myeleloid -derived suppressor cells, MDSCs),这是一种未成熟的中性粒细胞,具有很强的免疫抑制作用。循环MDSCs通过产生活性氧和精氨酸酶抑制T淋巴细胞的抗肿瘤免疫,并释放中性粒细胞胞外陷阱,促进肿瘤细胞在血液中的转运。肿瘤组织内的MDSCs通过表达PD-L1抑制T淋巴细胞功能,还可释放血管内皮生长因子促进血管生成,释放金属基质蛋白酶诱导上皮-间质转化,从而加重肿瘤进展。中性粒细胞在肿瘤发生发展中起重要作用。本文综述了中性粒细胞的起源以及中性粒细胞在循环和肿瘤组织中促进肿瘤进展的机制。关键词:肿瘤微环境;生物标志物;中性粒细胞;髓源性抑制细胞;免疫抑制
{"title":"The tumor promoting mechanism of circulating and tumor tissue neutrophils","authors":"Ji-Zhong Yin, Bing Li","doi":"10.3760/CMA.J.CN131368-20191015-01416","DOIUrl":"https://doi.org/10.3760/CMA.J.CN131368-20191015-01416","url":null,"abstract":"Neutrophils are the most common inflammation cells in the human body and the most abundant cells in the tumor microenvironment.Normal neutrophils are derived from bone marrow hematopoietic stem cells, which have the function of clearing pathogens and tissue repair.However, In the tumor background, the subpopulations of neutrophils can transform to Myeloid-derived suppressor cells (MDSCs), which is a kind of immature neutrophils with strong immunosuppressive effects.Circulating MDSCs inhibit the anti-tumor immunity of T lymphocytes by producing reactive oxygen species and arginase, and release neutrophil extracellular traps to promote tumor cell transport in blood.MDSCs in tumor tissues inhibit T lymphocytes function by expressing PD-L1, and can also release vascular endothelial growth factor to promote angiogenesis, release metal matrix protease to induce epithelial-mesenchymal transition, thereby aggravating tumor progression.Neutrophils play an important role in the development of tumorigenesis.This article reviews the origin of neutrophils and the mechanism by which neutrophils promote tumor progression in circulation and tumor tissues. \u0000 \u0000Key words: \u0000Tumor microenvironment; Biological markers; Neutrophils; Myeloid-derived suppressor cells; Immunity inhibition","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"52 1","pages":"536-540"},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88516844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective analysis of 93 cases of invasive fungal infection in children′s lung 93例儿童肺部侵袭性真菌感染回顾性分析
Pub Date : 2020-04-05 DOI: 10.3760/CMA.J.CN131368-20190604-00827
S. Gu, Yu-neng Lin, Shang-zhi Wu, Zhanhang Huang, Xiaowen Chen, Danhong Su, Y. Deng, Ying-ying Gu, De-hui Chen
Objective To explore the clinical manifestations, treatment and prognosis of pulmonaryinvasive fungal infection in children. Methods The clinical, imaging, laboratory examination, treatment and prognosis of 93 children with pulmonary invasive fungal infection that were to be diagnosed or confirmed in the Department of Pediatrics, the First Affiliated Hospital of Guangzhou Medical University, from January 2012 to August 2018 were analyzed retrospectively. Results Among the 93 fungal patients, 64 were male and 29 were female, with an age of (55.18±5.38) months, ranging from one month to 15 years, and a median age of 32 months.The average length of stay was 25.4 days, and the median length of stay was 23 days.The clinical manifestations of all patients were nonspecific, including fever, cough, expectoration, shortness of breath and dyspnea.The pulmonary imaging features were diverse, mainly including slightly thickened / increased lung texture, spot or patchy fuzzy shadow between the textures, accompanied by pulmonary consolidation, diffuse nodular change, etc.Bronchiectasis and mediastinal lymph node were rare.Among the 93 patients, 41 cases (44.1%) were positive for fungal culture in blood / deep sputum, and 22 cases (53.6%) were positive for Candida, two kinds of fungi were cultured in some patients at the same time.72 cases(77.4%) were effective in antifungal therapy, eight cases (8.6%) were abandoned because of basic diseases, six cases (6.5%) were transferred to other hospital, senven cases (7.5%) died.Among them, 41 cases (44.1%) were treated with voriconazole alone or in combination, 38 cases (92.7%) were effective, and three cases (7.3%) died. Conclusions Children with pulmonary invasive fungal infection are more likely to occur in children with serious underlying diseases.Their clinical and imaging manifestations are nonspecific.The mortality and prognosis are closely related to host factors, environmental factors and antifungal treatment.The use of voriconazole antifungal treatment can effectively reduce the mortality of children with pulmonary fungal infection. Key words: Lung diseases, fungal; Pneumonia; Child; Clinical analysis; Treatment
目的探讨儿童肺部侵袭性真菌感染的临床表现、治疗及预后。方法回顾性分析2012年1月至2018年8月在广州医科大学第一附属医院儿科诊断或确诊的93例肺部侵袭性真菌感染患儿的临床、影像学、实验室检查、治疗及预后。结果93例真菌患者中,男性64例,女性29例,年龄(55.18±5.38)个月,年龄1 ~ 15岁,中位年龄32个月。平均住院时间为25.4天,中位住院时间为23天。所有患者的临床表现均无特异性,主要表现为发热、咳嗽、咳痰、气短、呼吸困难。肺部影像学表现多样,主要表现为肺质地轻度增厚/增高,质地间斑点或斑片状模糊影,伴肺实变、弥漫性结节变等,支气管扩张及纵隔淋巴结少见。93例患者血/深痰真菌培养阳性41例(44.1%),念珠菌培养阳性22例(53.6%),部分患者同时培养两种真菌。抗真菌治疗有效72例(77.4%),因基础疾病放弃8例(8.6%),转院6例(6.5%),死亡7例(7.5%)。其中单用或联用伏立康唑41例(44.1%),有效38例(92.7%),死亡3例(7.3%)。结论儿童肺部侵袭性真菌感染多发生在有严重基础疾病的儿童中。其临床和影像学表现无特异性。致死率和预后与宿主因素、环境因素和抗真菌治疗密切相关。应用伏立康唑抗真菌治疗可有效降低肺部真菌感染患儿的死亡率。关键词:肺部疾病;真菌;肺炎;孩子;临床分析;治疗
{"title":"Retrospective analysis of 93 cases of invasive fungal infection in children′s lung","authors":"S. Gu, Yu-neng Lin, Shang-zhi Wu, Zhanhang Huang, Xiaowen Chen, Danhong Su, Y. Deng, Ying-ying Gu, De-hui Chen","doi":"10.3760/CMA.J.CN131368-20190604-00827","DOIUrl":"https://doi.org/10.3760/CMA.J.CN131368-20190604-00827","url":null,"abstract":"Objective \u0000To explore the clinical manifestations, treatment and prognosis of pulmonaryinvasive fungal infection in children. \u0000 \u0000 \u0000Methods \u0000The clinical, imaging, laboratory examination, treatment and prognosis of 93 children with pulmonary invasive fungal infection that were to be diagnosed or confirmed in the Department of Pediatrics, the First Affiliated Hospital of Guangzhou Medical University, from January 2012 to August 2018 were analyzed retrospectively. \u0000 \u0000 \u0000Results \u0000Among the 93 fungal patients, 64 were male and 29 were female, with an age of (55.18±5.38) months, ranging from one month to 15 years, and a median age of 32 months.The average length of stay was 25.4 days, and the median length of stay was 23 days.The clinical manifestations of all patients were nonspecific, including fever, cough, expectoration, shortness of breath and dyspnea.The pulmonary imaging features were diverse, mainly including slightly thickened / increased lung texture, spot or patchy fuzzy shadow between the textures, accompanied by pulmonary consolidation, diffuse nodular change, etc.Bronchiectasis and mediastinal lymph node were rare.Among the 93 patients, 41 cases (44.1%) were positive for fungal culture in blood / deep sputum, and 22 cases (53.6%) were positive for Candida, two kinds of fungi were cultured in some patients at the same time.72 cases(77.4%) were effective in antifungal therapy, eight cases (8.6%) were abandoned because of basic diseases, six cases (6.5%) were transferred to other hospital, senven cases (7.5%) died.Among them, 41 cases (44.1%) were treated with voriconazole alone or in combination, 38 cases (92.7%) were effective, and three cases (7.3%) died. \u0000 \u0000 \u0000Conclusions \u0000Children with pulmonary invasive fungal infection are more likely to occur in children with serious underlying diseases.Their clinical and imaging manifestations are nonspecific.The mortality and prognosis are closely related to host factors, environmental factors and antifungal treatment.The use of voriconazole antifungal treatment can effectively reduce the mortality of children with pulmonary fungal infection. \u0000 \u0000 \u0000Key words: \u0000Lung diseases, fungal; Pneumonia; Child; Clinical analysis; Treatment","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"36 1","pages":"531-535"},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91335779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlationship between oxidative damage and IP-10, Rantes in lung cancer patients 肺癌患者氧化损伤与IP-10、Rantes的关系
Pub Date : 2020-04-05 DOI: 10.3760/CMA.J.CN131368-20200316-01594
Jijie Chen, Huaying Cui, Chunhua Wei, jingyu zhao
Objective To investigate the possible associations of oxidative damage and serum chemokines, IFN-γ-inducible protein-10 (IP-10), Regulated on activation normal T-cell-expressed and secreted (Rantes) in lung cancer patients. Methods Blood samples were collected from 52 lung cancer patients as lung cancer group, 34 chronic bronchitis patients as the ratio of group and 20 healthy controls as healthy control group Who were admitted to the department of geriatrics of Dongying district people′s hospital from February 2018 to February 2019.The activities of serum superoxide dismutase (SOD) were measured by xanthine oxidase method, the levels of malondialdehyde (MDA) were detected by thiobarbituric acid colorimetric method (TBA) and the serum levels of IFN-γ-inducible protein-10 (IP-10), regulated on activation normal T-cell-expressed and secreted (Rantes) were measured by enzyme-linked immunosorbent assay (ELISA). Linear correlation analysis was used to analyze the correlationship. Results The activities of serum SOD were significantly lower in lung cancer group compared to the ratio of group and healthy control group (F=29.681, P<0.05). while the levels of MDA were significantly higher in lung cancer group compared to the ratio of group and healthy control group (F=61.151, P<0.05). In addition, the activities of SOD were correlated to clinical stages in patients with lung cancerⅠ~Ⅳ period, the difference was statistically significant (F=11.734, P<0.05). The levels of IP-10 and Rantes were higher in lung cancer group than the ratio of group and healthy control group (F=22.115, 13.181, P<0.05). The levels of IP-10 and Rantes were negatively correlated with the activities of SOD (r=-0.309, -0.376, P=0.017, 0.034), while positively correlated with the levels of MDA (r=0.357, P=0.021). Conclusions Strong associations were found between chemokines and oxidative stress which participated in the pathogenesis of lung cancer. Key words: Lung neoplasms; Superoxide dismutase; Malondialdehyde; IFN-γ-inducible protein-10; Regulated on activation normal T-cell-expressed and secreted
目的探讨肺癌患者血清趋化因子IFN-γ-诱导蛋白-10 (IP-10)活化正常t细胞表达和分泌(Rantes)与氧化损伤的关系。方法采集2018年2月至2019年2月东营区人民医院老年病科收治的肺癌患者52例作为肺癌组,慢性支气管炎患者34例作为对照组,健康对照组20例作为健康对照组。黄嘌呤氧化酶法检测血清超氧化物歧化酶(SOD)活性,硫代巴比妥酸比色法(TBA)检测丙二醛(MDA)水平,酶联免疫吸附法(ELISA)检测血清中调节正常t细胞表达和分泌的IFN-γ诱导蛋白-10 (IP-10)水平。采用线性相关分析分析相关性。结果肺癌组血清超氧化物歧化酶活性明显低于对照组和健康对照组(F=29.681, P<0.05)。肺癌组MDA水平明显高于对照组和健康对照组(F=61.151, P<0.05)。此外,SOD活性与肺癌患者Ⅰ~Ⅳ期临床分期相关,差异有统计学意义(F=11.734, P<0.05)。肺癌组IP-10、Rantes水平高于对照组和健康对照组(F=22.115、13.181,P<0.05)。IP-10、Rantes水平与SOD活性呈负相关(r=-0.309、-0.376,P=0.017、0.034),与MDA水平呈正相关(r=0.357, P=0.021)。结论趋化因子与氧化应激密切相关,参与了肺癌的发病过程。关键词:肺肿瘤;超氧化物歧化酶;丙二醛;干扰素-γ诱导protein-10;受激活正常t细胞表达和分泌的调控
{"title":"Correlationship between oxidative damage and IP-10, Rantes in lung cancer patients","authors":"Jijie Chen, Huaying Cui, Chunhua Wei, jingyu zhao","doi":"10.3760/CMA.J.CN131368-20200316-01594","DOIUrl":"https://doi.org/10.3760/CMA.J.CN131368-20200316-01594","url":null,"abstract":"Objective \u0000To investigate the possible associations of oxidative damage and serum chemokines, IFN-γ-inducible protein-10 (IP-10), Regulated on activation normal T-cell-expressed and secreted (Rantes) in lung cancer patients. \u0000 \u0000 \u0000Methods \u0000Blood samples were collected from 52 lung cancer patients as lung cancer group, 34 chronic bronchitis patients as the ratio of group and 20 healthy controls as healthy control group Who were admitted to the department of geriatrics of Dongying district people′s hospital from February 2018 to February 2019.The activities of serum superoxide dismutase (SOD) were measured by xanthine oxidase method, the levels of malondialdehyde (MDA) were detected by thiobarbituric acid colorimetric method (TBA) and the serum levels of IFN-γ-inducible protein-10 (IP-10), regulated on activation normal T-cell-expressed and secreted (Rantes) were measured by enzyme-linked immunosorbent assay (ELISA). Linear correlation analysis was used to analyze the correlationship. \u0000 \u0000 \u0000Results \u0000The activities of serum SOD were significantly lower in lung cancer group compared to the ratio of group and healthy control group (F=29.681, P<0.05). while the levels of MDA were significantly higher in lung cancer group compared to the ratio of group and healthy control group (F=61.151, P<0.05). In addition, the activities of SOD were correlated to clinical stages in patients with lung cancerⅠ~Ⅳ period, the difference was statistically significant (F=11.734, P<0.05). The levels of IP-10 and Rantes were higher in lung cancer group than the ratio of group and healthy control group (F=22.115, 13.181, P<0.05). The levels of IP-10 and Rantes were negatively correlated with the activities of SOD (r=-0.309, -0.376, P=0.017, 0.034), while positively correlated with the levels of MDA (r=0.357, P=0.021). \u0000 \u0000 \u0000Conclusions \u0000Strong associations were found between chemokines and oxidative stress which participated in the pathogenesis of lung cancer. \u0000 \u0000 \u0000Key words: \u0000Lung neoplasms; Superoxide dismutase; Malondialdehyde; IFN-γ-inducible protein-10; Regulated on activation normal T-cell-expressed and secreted","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"78 1","pages":"516-520"},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77230124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress of obstructive sleep apneahypopnea syndrome and coronary heart disease 阻塞性睡眠呼吸暂停综合征与冠心病的研究进展
Pub Date : 2020-04-05 DOI: 10.3760/CMA.J.CN131368-20190514-00739
Chunlei Shao, Wenjiao Jiang, Linna Jiang, H. Yue
Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a disorder of recurrent hypoxia and daytime sleepiness caused by airway collapse during sleep.Obstructive sleep apnea-hypopnea syndrome is closely related to cardiovascular diseases such as hypertension, arrhythmia, coronary atherosclerotic heart disease and heart failure.OSAHS plays an important role in promoting the occurrence and development of cardiovascular diseases.Currently, OSAHS as an important risk factor of coronary atherosclerotic heart disease is gradually paid attention to.This article reviews the pathogenesis of OSAHS induced coronary heart disease, the relationship between OSAHS and coronary artery stenosis, the adverse prognosis of OSAHS combined with coronary heart disease and the effect of continuous positive airway pressure on the prognosis of these patients. Key words: Sleep apnea, obstructive; Coronary artery disease; Coronary stenosis; Continuous positive airway pressure; Pathogenesis
阻塞性睡眠呼吸暂停低通气综合征(OSAHS)是一种由睡眠时气道塌陷引起的反复缺氧和日间嗜睡的疾病。阻塞性睡眠呼吸暂停低通气综合征与高血压、心律失常、冠状动脉粥样硬化性心脏病、心力衰竭等心血管疾病密切相关。OSAHS在心血管疾病的发生发展中起着重要的促进作用。目前,OSAHS作为冠状动脉粥样硬化性心脏病的重要危险因素逐渐受到重视。本文就OSAHS诱发冠心病的发病机制、OSAHS与冠状动脉狭窄的关系、OSAHS合并冠心病的不良预后以及持续气道正压对患者预后的影响等方面进行综述。关键词:睡眠呼吸暂停;阻塞性;冠状动脉疾病;冠状动脉狭窄;持续气道正压;发病机理
{"title":"Research progress of obstructive sleep apneahypopnea syndrome and coronary heart disease","authors":"Chunlei Shao, Wenjiao Jiang, Linna Jiang, H. Yue","doi":"10.3760/CMA.J.CN131368-20190514-00739","DOIUrl":"https://doi.org/10.3760/CMA.J.CN131368-20190514-00739","url":null,"abstract":"Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a disorder of recurrent hypoxia and daytime sleepiness caused by airway collapse during sleep.Obstructive sleep apnea-hypopnea syndrome is closely related to cardiovascular diseases such as hypertension, arrhythmia, coronary atherosclerotic heart disease and heart failure.OSAHS plays an important role in promoting the occurrence and development of cardiovascular diseases.Currently, OSAHS as an important risk factor of coronary atherosclerotic heart disease is gradually paid attention to.This article reviews the pathogenesis of OSAHS induced coronary heart disease, the relationship between OSAHS and coronary artery stenosis, the adverse prognosis of OSAHS combined with coronary heart disease and the effect of continuous positive airway pressure on the prognosis of these patients. \u0000 \u0000Key words: \u0000Sleep apnea, obstructive; Coronary artery disease; Coronary stenosis; Continuous positive airway pressure; Pathogenesis","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"29 1","pages":"556-560"},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75462588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese Journal of Asthma
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1